Gold Standard Diagnostics
2851 Spafford Street
Suite A
Davis
California
95618
United States
Tel: 530-759-8000
Fax: 530-759-8012
About Gold Standard Diagnostics
20 articles about Gold Standard Diagnostics
-
Improved Lyme Screening Assay Now FDA Cleared for Laboratory Use
4/20/2021
Gold Standard Diagnostics announced it offers a new B. burgdorferi VlsE-OspC IgG/IgM recombinant ELISA Screen that can be used to improve workflow and conserve testing resources.
-
Gold Standard Diagnostics Receives FDA 510K for Lyme IgG and IgM EIA Kits
10/5/2020
The Gold Standard Diagnostics Group (GSD) today announced the immediate availability of their two new Lyme IgG and Lyme IgM EIA kits for detection of antibodies against Lyme disease causing bacteria. The two assays give laboratories a more diverse arsenal of testing methodologies that allows them to achieve more reliable results. The assays are available immediately in the US. The separate IgG and IgM assays provide la
-
Gold Standard Diagnostics Multiplex Real-Time PCR Assay for SARS-CoV-2 Pathogen Detection Now Available in the US
5/18/2020
Gold Standard Diagnostics Inc. today announced the EUA submission of a Multiplex Real-Time, reverse-transcriptase polymerase chain reaction (RT-PCR) assay for the direct qualitative pathogen detection of the novel coronavirus (SARS-CoV-2). The assay is available now for purchase in the U.S. Particularly in the early phase of COVID-19 infection, the direct and precise diagnostic of the pathogen is critical. PCR is the method
-
Gold Standard Diagnostics COVID-19 Antibody Tests Now Available
4/17/2020
The Gold Standard Diagnostics Group including Gold Standard Diagnostics Inc., VIROTECH Diagnostics GmbH, and NovaTec Immundiagnostica GmbH announced the immediate availability of three different serological assays for detection of antibodies against the novel coronavirus SARS-CoV-2.
-
FDA Clears Gold Standard Diagnostics’ Borrelia burgdorferi IgG/IgM ELISA Assay
6/13/2018
The test is intended as an initial screening assay in the CDC recommended two-steps testing for evidence of antibodies against the Lyme disease bacteria
-
R-Biopharm AG And Gold Standard Diagnostics Announce Strategic Alliance
6/23/2016
-
Gold Standard Diagnostics Receives FDA Clearance for the AIX1000TM System
3/7/2016
-
Gold Standard Diagnostics’ and DIAsource ImmunoAssays’ 25-OH Vitamin D, Total Assay Receives 510k FDA Clearance
7/24/2013
-
Gold Standard Diagnostics' Next-Generation Lyme Disease Testing Becoming Widely Accepted Amongst Clinical Laboratories
6/19/2013
-
Gold Standard Diagnostics Expands ThunderBolt® Laboratory Automation Platform International Sales and Marketing Network
3/19/2013
-
Gold Standard Diagnostics Release: Streamline Parasitology Testing With Reliable Procurement and Broad Product Offering
11/14/2012
-
Gold Standard Diagnostics Release: Enhance Free Testosterone Testing With FDA Cleared Direct Detection
9/5/2012
-
Gold Standard Diagnostics Release: Boost Clinical Lab Efficiency With the ThunderBolt® EIA+CLIA Automation Platform
7/17/2012
-
Gold Standard Diagnostics Announces Next Generation HE4 Ovarian Cancer Biomarker Testing Solutions
6/13/2012
-
Gold Standard Diagnostics Launches Axis-Shield PLC’s New and Improved Anti-CCP2 Assay for Early and Accurate Diagnosis of Rheumatoid Arthritis
12/6/2011
-
Gold Standard Diagnostics Extends Relationship with Fujirebio Diagnostics, Inc. and Signs an Exclusive US Distribution Agreement for Cyfra 21-1 EIA
10/17/2011
-
Gold Standard Diagnostics Signs U.S. Distribution Agreement With Fujirebio Diagnostics, Inc. for Multi-Constituent Tumor Marker Control
7/13/2011
-
Gold Standard Diagnostics Introduces the ThunderBolt Automated Diagnostics Platform
7/27/2010
-
Gold Standard Diagnostics Signs Exclusive US Distribution Agreement With Axis-Shield PLC for Homocysteine
6/30/2010
-
Gold Standard Diagnostics Completes Series A Funding; Gold Standard Diagnostics Plans to Double Staff This Year
3/2/2010